p = 0.0001), followed by dulaglutide (OR = 0.18
With tirzepatide's potent appetite suppression and substantial weight reduction, patients may experience more pronounced lean mass changes compared to modest lifestyle interventions, simply because total weight loss is greater
At three months, researchers found participants who received semaglutide had a decreased risk for major adverse cardiovascular events (MACE), which included non-fatal heart attack, non- fatal stroke or cardiovascular death
But even in these cases, a gradual taper is usually preferable to an abrupt stop
Semaglutide (Wegovy/Ozempic) is a breakthrough obesity treatment offering sustainable, clinically significant weight loss with additional metabolic benefits
Based on these findings, our medical team creates a customized tirzepatide dosing protocol tailored to your individual health goals